leisure time -WSS

leisure time

author：fashion 2025-09-06 03:26:14 - browse：89

Stock illustration of computer and medication — Adobe

Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

“My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

WSS

Just how do doctors, lawmakers, and the public define abortion?

What PEPFAR has meant on the ground in Ukraine

AI models in health care face new federal disclosure requirements

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Leukemia patients are helped by Syndax's new type of therapy

IVF, abortion rights issues kick off Biden’s State of the Union

Wikipedia

leisure time

focus

Affirmative action in medical school literally saved lives

A deep dive into Applied Therapeutics’ data, and questions on Cassava

In age of alternative facts, a scholarly course on calling out crap

FDA approves world's first CRISPR

Peter Hotez and the public health issue of online harassment

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Dobbs anniversary: the lost opportunity of abortion as health care

Air quality improving but still lags in Black, Hispanic communities

entertainment

What causes an itch? Researchers may have solved the mystery

Supreme Court wrestles with OxyContin maker's bankruptcy deal

After sickle

STAT letters to the editor on burnt

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

How to bring more disabled researchers into academia

focus

focus

explore

entertainment